Navigation Links
InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today.
Date:9/24/2010

- title -->

InspireMD Presents 2 Years Clinical Outcome of MGuard Multicenter Experience in STEMI Patients. The New Superb Clinical Results Were celebrated at InspireMD's TCT Satellite Symposium in Washington DC., Today.

 

WASHINGTON, September 24, 2010 /PRNewswire/ -- InspireMD sponsored a Satellite Symposium today at the TCT conference in Washington convention center, the symposium was chaired by Drs. Alexandra J. Lansky,and Roxana Mehran. The session titled "MGuard Embolic Protection Stent: Novel Primary PCI Solutions and Challenging Cases" manifested unprecedented clinical findings of long term MGuard Multicenter Experience in STEMI (heart attack) patients, presented by Prof. Federico Piscione, from Federico-II University in Naples, Italy. Prof. Piscione presented 2 years clinical follow up of 100 patients. In an analysis of non cardiogenic shock patients (89 patients), the MACE (cardiac death, MI, TVR) rate was 7.9% (vs. 13.3% in the total group). In addition, post procedural Blush grade 3 and complete ST segment resolution were both at 90%.

"The results we obtained with the MGuard stent" commented Prof. Piscione," show that MGuard is a safe and feasible option, both at short and long-term follow-up, for STEMI patients undergoing PCI with huge thrombus burden."

Mr. Ofir Paz, InspireMD's CEO, said "We are very excited with the new clinical results of MGuard. To date, 345 STEMI patients have been enrolled in selected clinical trials to test MGuard performance in this high risk population. The outcome surpasses today's best practice, in terms of acute results as well as long term clinical follow-up. When we performed a Meta analysis of all our STEMI trials the results reveal that with MGuard it may be possible to reduce MACE by up to an astonishing 50%."

About MGuard(TM) Coronary

MGuard(TM) presents a novel combination of a coronary stent merged with an embolic p
'/>"/>

SOURCE Inspire MD
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. InspireMD Announces Enrollment of First Patients in the MGuard(TM) Acute Myocardial Infarction Clinical Trial Data Will be Used to Confirm Initial Positive Results
2. MGuard(TM), InspireMDs Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008
3. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
4. InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry. InspireMD Will Also Sponsor a Satellite Program Breakfast Meeting at the TCT Conference on September 24th 2009 in the Moscone Exhibition Center in San Francisco
5. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
6. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
7. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
8. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
9. GeoVax Presents Data at AIDS Vaccine 2008 Conference
10. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
11. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... WIEN , July 3, 2015 /PRNewswire/ ... indtil den 22. september 2015 på  http://www.openinnovationinscience.at ... in Science", der finder sted i ... en nylig undersøgelse af internationale forskere og ... er de to største udfordringer for sundhedsvidenskaben ...
(Date:7/2/2015)... ... July 02, 2015 , ... Sleepless nights will become obsolete ... of sleep, launched its Indiegogo campaign on June 23. Sound sleepers and the sleep ... makes it effortless to use, while the integration of the Bluetooth speaker, alarm clock ...
(Date:7/1/2015)... ... , ... The next-generation sequencing (NGS) clinical market is poised for huge growth ... BCC Research reveals in its new report that the market drivers of this vibrant ... need for better diagnostics as part of a molecular diagnostics trend. , The global ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan contest ... the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup Challenge ... of US$15,000 and a period of expert mentorship from a senior industry figure drawn ...
Breaking Biology Technology:Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
... Pacira Pharmaceuticals, Inc., an,acute care specialty pharmaceutical company, today ... addition of a key senior,executive to the company,s management ... a seasoned biopharmaceutical executive with more than,30 years of ... Pacira as the founder and past Chairman and CEO ...
... WOODCLIFF LAKE, N.J., July 9 Par,Pharmaceutical Companies, Inc. ... shipment of 12.5mg and 25mg meclizine HCl tablets immediately. ... of the AB-rated,generic product., Par marketed meclizine prior ... in February 2008. Par has since qualified a new ...
... 9 /PRNewswire-FirstCall/ - Lorus Therapeutics Inc. (TSX:,LOR, ... biopharmaceutical company,specializing in the research and development ... of cancer, today announced progress made in,the ... two,research studies on the Virulizin(R) mode of ...
Cached Biology Technology:Pacira Pharmaceuticals, Inc. Adds Board Member and Key Senior Management 2Par Pharmaceutical to Launch meclizine HCL Tablets 2Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 2Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 3Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 4Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 5Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program 6
(Date:7/2/2015)... , July 2, 2015 Fingerprint ... FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World Peace ... of FPC,s distributors in Asia . Deliveries ... The sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of approximately 2,200 ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... about smoking, diet, exercise and available methods of ... half of all cancers nationwide. This ... host its Ninth Annual International Conference on Frontiers ... Center, located in Philadelphia. Thousands of scientists will ...
... Carolina State University finds that fish located near coal-fired power ... much further away. The surprising finding appears to be linked ... facilities, which unfortunately poses problems of its own. "We ... (km) from a coal-fired power plant had mercury levels more ...
... Sensation seekingthe urge to do exciting thingshas been linked to ... a new study published in Psychological Science, a ... in the dopamine system and found a group of mutations ... Sensation seeking has been linked to a range of ...
Cached Biology News:Study: Fish near coal-fired power plants have lower levels of mercury 2A thirst for excitement is hidden in your genes 2
... computing power of your ValveBank system! ... with a Macintosh computer using graphic 'click-and-drag' ... disk, print out program listings, then download ... one simple step., EasyCode is used for ...
... MSC series of Class II Biological ... and certification to the world's highest ... that the cabinets cannot be adjusted ... lighting, low noise and arm rest ...
... 2010 Class II Biological Safety Cabinets ... of comfort while incorporating the latest ... operator, environment and product protection with ... recirculated air.,Bottom filters are safely exchanged ...
... The Magnetic Stand-96 is designed for paramagnetic ... and 0.2 ml PCR plates with no ... polyacryl base in a standard SBS 96-well ... strong permanent magnets guarantees easy and fast ...
Biology Products: